Effect of Sotrovimab on Hospitalization or Death Among High-

This randomized clinical trial compares the efficacy and adverse events of sotrovimab vs placebo in preventing progression of mild to moderate COVID-19 to sever

Related Keywords

Spain , Helsinki , Eteläuomen Läi , Finland , United States , Juarez , Méco , Mexico , Peru , Canada , Brazil , America , American , Crespo Casal , Adriennee Shapiro , Eli Lilly , Rodrigues Falci , Glaxosmithkline , Vir Biotechnology Inc , Gilead Sciences , Group Information , York Heart Association , National Institute Of Allergy , Pfizer , International Council For Harmonisation , Institute Inc , Fred Hutchinson Cancer Research Center , Council For International Organizations Of Medical Sciences , Antibody Efficacy Trial , Care Early , International Organizations , Medical Sciences , Good Clinical Practice , International Council , New York Heart Association , North America , South America , Secondary Outcomes , Influenza Patient Reported Outcome Plus , North American , Clinical Characteristics , Interest Disclosures , Vir Biotechnology , United Medical , Merck Sharp , Drs Zheng , Drs Austin , Viiv Healthcare , National Institute ,